MEDICAL DEVICES · SERVICE DETAILS

QMSR Quality System Compliance Support

In conjunction with products, manufacturing and outsourcing activities, document, training, follow-up and inspection readiness support is provided on an agreed basis against existing Parts 820 and ISO 13485:2016.

Counselling does not amount to certification of the FDA system or through assurance of inspection. Enterprises should implement procedures, real records and improvements; Third-party certification, technical certification, regulatory reporting and other special scopes are identified separately.

SERVICE OVERVIEW

What does this service help with?

(b) To establish the correspondence between the applicable requirements, procedures, records and those responsible, based on real operations and the existing system. The agreed delivery gap list, document amendments to recommendations, training and implementation of collaborative records and matters to be improved could be avoided by changing only the standard name instead of the actual controls.

WHO MAY NEED IT

Who should consider this service?

Manufacturers of finished instruments subject to the application requirements of QMSR, as well as quality regulation teams involved in design, specifications development, outsourcing and other corresponding activities. Specific scope and exceptions are judged by activity and apparatus.

SCOPE & APPROACH

QMSR Quality system compliance support can include what?

System application, document revision, physical execution and inspection preparation for disaggregation, with certification as a basis for information and not as a substitute for FDA requirements.

01

Verification of products, activities and scope of application

Combination of products and premises, manufacturing and outsourcing activities, and checking of QMSR scope, definitions and specific exceptions to form a catalogue of items and bases to be confirmed.

02

Analysis of existing systems and gaps

Review existing procedures and records against the application of Part 820 and reference criteria, ranking gaps by risk, responsibility and impact and recommendations for improvement.

03

FDA Supplement and related interfaces

Reconcile interfaces such as complaint maintenance records, label packaging, UDI and applicable reports to identify additional duties and controls; The actual special declaration is otherwise agreed.

04

Collaboration between documentation, duties and training

Revision of the procedures or record template according to the recognition scope to identify business approvals, training and executives to avoid the delivery of the template as operational completion.

05

Implementation record and issue improvement follow-up

Conduct evidence, corrective measures and impact verification on an agreed review basis to assist in the documentation of management review, internal review and vendor management-related issues.

06

Check readiness and information access support

Check the consistency between the availability and interpretation of records and the preparation of catalogues of information and the tracking of gaps, based on existing inspection arrangements; Do not commit to FDA inspection findings.

GET READY

What to prepare for the assessment

Initial communication may be preceded by a summary and a catalogue of existing records; Detailed information is transferred to the confidentiality arrangements under delegated authority.

  • List of products, sites, actual manufacturing designs and outsourced activities
  • Quality manuals, procedures, document catalogues and responsibilities
  • Authentication, audit, inspection and historical change information available
  • Designed production, supplier, risk and associated implementation records
  • Recording of complaints, maintenance, label packaging, UDI and regulatory interfaces
  • Directory of training, management reviews, internal reviews and proposed improvements
HOW TO START

From initial review to engagement

STEP 01

Scope determination and information base

Reconciling activities and applicable conditions, confirming confidential authorizations, existing documents and the objective.

STEP 02

Analysis of gaps and clear plans

Identify documentation and implementation gaps, and agree on priorities, responsibilities, milestones and costs.

STEP 03

Collaborative revision, training and implementation

Documentation and training support is provided on an agreed basis and is implemented and documented by the enterprise.

STEP 04

Review and improvement of the handover

Follow-up on the implementation of evidence and legacy and clear responsibility for continuous improvement and inspection preparedness.

Counselling does not amount to certification of the FDA system or through assurance of inspection. Enterprises should implement procedures, real records and improvements; Third-party certification, technical certification, regulatory reporting and other special scopes are identified separately.

TIMING & FEES

Timing and fees

Information reviewed:Cost application period: current QMSR requirements; Official data check: 2026-11-06. Consultancy and third-party costs are recognized separately by scope.

Timing and preparation

Document preparation

(a) Plans for the pacing phase by venue, product and process size, existing documentation and documentation gaps, training and actual implementation; The full implementation cycle cannot be estimated by the number of pages.

FDA processing

QMSR has been in effect since 2026-02-02. Implementation and improvement are ongoing. There is no standard FDA quality system certification timeline. Inspections and follow-up depend on the applicable procedures and facts.

Fee breakdown

FDA fees

There is no independent FDA accreditation fee for this system consultancy; Matters relating to the application of registration, declaration, third-party certification and inspection require separate checks.

Service fees

Phased quotations based on applicable assessments, gap analysis, volume of documentation, training, review implementation and scope of inspection preparation, identification of on-site or remote approaches and feedback rounds.

Other possible costs

Third-party certification, standard text acquisition, test validation, translation and other professional work are shown separately on a practical basis; Business registers, listings and regulatory submissions are not automatically included.

OFFICIAL SOURCES

Official grounds for application and maintenance

Data check: 2026-11-06. Specific obligations shall be confirmed in conjunction with the equipment, activities and current application requirements of the FDA.

START WITH YOUR PRODUCT

An inventory of business activities and systems is provided first.

Identify products, sites, ISO systems in place and issues to be addressed, and identify gaps assessments, documentation and implementation support.